Agilent to Sell $750M in Notes | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agilent Technologies today said that it would offer $750 million worth of senior notes through two offerings.

The firm has not filed a final prospectus yet on the offerings. However, in a statement, Agilent said that it would use the proceeds to satisfy, in part, the financing obligation of Agilent Technologies World Trade, the subsidiary that acquired Varian for $1.5 billion in May.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.